Recombinant Proteins

Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Form
- (1)
- (1)
- (22,552)
- (4,966)
- (29)
- (22)
- (26)
- (27)
For Use With (Application)
- (2)
- (79)
- (3)
- (1)
- (3)
- (1)
- (3)
- (20,923)
- (1)
- (1)
- (2)
- (6)
- (44)
- (2)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (1)
- (3)
- (5)
- (10)
- (21,513)
- (1)
- (2)
- (1)
- (1)
- (2,305)
- (1)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (8)
- (4,693)
- (134)
- (1)
- (1)
- (4)
- (1)
- (20)
- (3)
- (251)
- (25)
- (5)
- (2)
- (13)
- (1)
- (1,226)
- (2)
- (19)
- (26)
- (1)
- (2)
- (1)
- (18)
- (2)
- (3)
- (4)
- (1)
- (7)
- (3)
- (1)
- (1)
- (64)
- (3)
- (6)
- (1)
- (6)
- (7)
- (5)
- (1)
- (1)
- (7)
- (6)
- (3)
- (14)
- (2)
- (4)
- (4)
- (6)
- (1)
- (2,302)
- (1)
- (1)
Recombinant
- (68)
- (27,494)
Conjugate
- (11)
- (1)
- (4)
- (2)
- (9)
- (7)
- (1)
- (7)
- (3)
- (1)
- (4)
- (6)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (2)
- (27,209)
Species
- (1)
- (9)
- (25)
- (2)
- (1)
- (274)
- (22,463)
- (2)
- (62)
- (1)
- (2)
- (1)
- (1)
- (4)
- (8)
- (3)
- (179)
- (13)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.

1
–
15
of
23,698
results
Purity or Quality Grade | ≥98% by HPLC |
---|---|
Conjugate | Unconjugated |
Form | Lyophilized |
Molecular Weight (g/mol) | 4.3 kDa |
Formulation | protein with no preservative |
Sequence | H2N-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-ValPhe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
For Use With (Application) | Control,ELISA,Immunohistochemistry,Western Blot |
Name | Human beta Amyloid (1-40) |
Recombinant | Recombinant |
Invitrogen™ Cholera Toxin Subunit B (Recombinant), Biotin-XX Conjugate
Made from a recombinant version of the B subunit only to provide a very high-purity product that is completely free of the toxic A subunit
Invitrogen™ Isolectin GS-IB4 From Griffonia simplicifolia, biotin-XX Conjugate
Isolated from the seeds of Griffonia simplicifolia, a tropical African legume
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IL-17 F |
Molecular Weight (g/mol) | 30.1 kDa |
Gene Symbol | IL17F |
Endotoxin Concentration | <0.1 EU/ μg |
Sequence | MRKIPKVGHT FFQKPESCPP VPGGSMKLDI GIINENQRVS MSRNIESRST SPWNYTVTWD PNRYPSEVVQ AQCRNLGCIN AQGKEDISMN SVPIQQETLV VRRKHQGCSV SFQLEKVLVT VGCTCVTPVI HHVQ |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human IL-17 F, Animal-Free |
Accession Number | Q96PD4 |
Regulatory Status | RUO |
Gene Alias | C87042; CANDF6; cytokine ML-1; IL17F; IL-17 F; IL-24; ILN; Interleukin; interleukin 17 F; Interleukin17F; interleukin-17 F; interleukin-24; ML1; ML-1; mutant IL-17 F |
Biological Activity | Measured by its ability to induce IL-6 production by NHDF cells. |
Gene ID (Entrez) | 112744 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Protein Family | Kinases & Inhibitors |
---|---|
Content And Storage | -80°C, Avoid Freeze/Thaw Cycles |
Conjugate | Unconjugated |
Form | Liquid |
Common Name | LRRK2 (WT) |
Molecular Weight (g/mol) | 288 kDa |
KinaseFamily | LRRK Kinase Family |
Sequence | Full length |
Concentration | See Label |
Expression System | Baculovirus |
For Use With (Application) | Kinase Assay |
Name | LRRK2 (WT) |
Accession Number | Q5S007 |
Gene Alias | LRRK2 |
Protein Form | Recombinant, Full Length |
Gene ID (Entrez) | 120892 |
Formulation | proprietary buffer with no preservative |
Research Category | Neurobiology |
Protein Tag | DYKDDDDK-tag |
Species | Human |
Recombinant | Recombinant |
Invitrogen™ Vaccinia Virus B18R (Carrier-Free) Recombinant Protein, eBioscience™
Recombinant Protein
Content And Storage | -80°C |
---|---|
Purity or Quality Grade | >98% by SDS-PAGE |
Conjugate | Unconjugated |
Form | Liquid |
pH Range | 7.5 |
Common Name | Vaccinia Virus B18R |
Molecular Weight (g/mol) | 48 kDa |
Gene Symbol | Vaccinia Virus-Encoded Neutralizing Type I Interferon Receptor; Type I IFN inhibitor |
Endotoxin Concentration | <0.01 ng/μg |
Sequence | Vaccinia Virus B18R, ammino acids His20-Glu351 (Accession # D01019) with a His-tag |
Concentration | 0.5 mg/mL |
Expression System | Insect cells |
For Use With (Application) | Control,Functional Assay |
Source | Vaccinia Virus |
Protein Subtype | Recombinant |
Name | Vaccinia Virus B18R (Carrier-Free) |
Regulatory Status | RUO |
Purification Method | SDS-PAGE |
Product Type | Recombinant Protein, Carrier-Free |
Biological Activity | Pre-incubation of recombinant IFN-alpha 2 A with 0.1 μg/mL B18R for 1 hour (at RT was found to completely neutralize the activity of 1 ng/mL IFN-alpha 2 a.) |
Formulation | PBS with no preservative; pH 7.5 |
Shelf Life | 12 Months |
Protein Tag | His-tag |
Species | Vaccinia virus |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IL-1 alpha |
Molecular Weight (g/mol) | 17.9 kDa |
Gene Symbol | Il1a |
Endotoxin Concentration | <1 EU/ μg |
Sequence | SAPYTYQSDL RYKLMKLVRQ KFVMNDSLNQ TIYQDVDKHY LSTTWLNDLQ QEVKFDMYAY SSGGDDSKYP VTLKISDSQL FVSAQGEDQP VLLKELPETP KLITGSETDL IFFWKSINSK NYFTSAAYPE LFIATKEQSR VHLARGLPSM TDFQIS |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Mouse IL-1 alpha |
Accession Number | P01582 |
Regulatory Status | RUO |
Gene Alias | CTLA8; hematopoietin-1; IL 1 A; IL 1 A; IL1; IL-1 alpha; IL17; IL1A; Il-1 A; IL-1 alpha; IL1-ALPHA; IL1F1; IL1a; ILN; Interleukin; interleukin 1 alpha; interleukin 1, alpha; interleukin 17; interleukin 1 A; interleukin 1-alpha; interleukin 1-alpha (AA 1 - 152); Interleukin1 alpha; interleukin-1 alpha; interleukin-1 alpha precursor; Interleukin-17 A; preinterleukin 1 alpha; pre-interleukin-1 alpha; pro-interleukin-1-alpha; RP23-160G19.8 |
Biological Activity | The ED50 as determined by the dose-dependent stimulation of murine D10S cells is ≤ 0.002 ng/ml, corresponding to a specific activity of ≥ 5 x 10^8 units/mg |
Gene ID (Entrez) | 16175 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Source | Human |
---|---|
Recombinant | Recombinant |
Name | rLaminin-521, Human |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | GHELSHPFCYHPEVIKYTYSKPWISS |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human OR51T1 (aa 173-198) Control Fragment |
Recombinant | Recombinant |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | MELENQTRVTKFILVGFPGSLSMR |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human OR6B1 (aa 1-24) Control Fragment |
Recombinant | Recombinant |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | LAQDLEDMWEQKFLQFKLGARITEADEKNDRTSLNRKLDRNLVLLVREKFGDQDVWILPQAEWQPGETLRGTAERTLATLSE |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human MRPL46 (aa 116-197) Control Fragment |
Recombinant | Recombinant |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | FVDEVRAIIPRVPSLSVPWLQDRIEDSGENLETEPLESQDRELLDTSFEDLSKPKRKLADGRQASVTLQPLKIKKLIPNPNKIRKPPKS |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human RPP38 (aa 189-277) Control Fragment |
Recombinant | Recombinant |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | VRFIYEAWQGVERDLRGQVPGGERGLVEEYVEKVPNPSLKTFKPIDLSDLKRRSTQDAKKS |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human FAM195B (aa 37-97) Control Fragment |
Recombinant | Recombinant |
Regulatory Status | RUO |
---|---|
Purity or Quality Grade | >80% by SDS-PAGE and Coomassie blue staining |
Conjugate | Unconjugated |
Form | Liquid |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Sequence | SAQPRPPSVVHESRSAVSSRTKTSKLVEDH |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay,Control |
Name | Human OGDHL (aa 85-114) Control Fragment |
Recombinant | Recombinant |